Intelligence · Clinical Pipeline
Oramed Pharmaceuticals Pipeline
All ClinicalTrials.gov programs at Oramed Pharmaceuticals — phase, modality, and trial IDs.
- Programs
- 10
Quick answer
Oramed Pharmaceuticals has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Cohort A: ORMD-0801
ORAMED PHARMACEUTICALS INC.
T2DM (Type 2 Diabetes Mellitus)
1 trial -
ORMD 0801
ORAMED PHARMACEUTICALS INC.
Brittle Type I Diabetes Mellitus
1 trial -
ORMD-0801
ORAMED PHARMACEUTICALS INC.
Diabetes Type 2
1 trial -
ORMD-0801 (Insulin) capsule 8 mg BD
ORAMED PHARMACEUTICALS INC.
Diabetes Mellitus, Type 2
1 trial -
ORMD-0801 Capsules
ORAMED PHARMACEUTICALS INC.
Diabetes Mellitus Type 1
1 trial -
ORMD-0801 Dose # 1
ORAMED PHARMACEUTICALS INC.
Diabetes Mellitus Type 2
1 trial -
ORMD-0801 QD
ORAMED PHARMACEUTICALS INC.
Nonalcoholic Steatohepatitis (NASH)
1 trial -
ORMD-0801 Treatment A
ORAMED PHARMACEUTICALS INC.
Type 1 Diabetes
1 trial -
ORMD-0801 capsules- 2x8mg
ORAMED PHARMACEUTICALS INC.
Type 1 Diabetes
1 trial -
Oral Insulin
ORAMED PHARMACEUTICALS INC.
Non-Alcoholic Steatohepatitis (NASH)
1 trial
Frequently asked questions
How many pipeline programs does Oramed Pharmaceuticals have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs